CEO Galit Zuckerman-Stark writes in Innovations in Pharmaceutical Technology how Medasense’s innovation provides an objective approach that could help healthcare professionals better assess pain.
To read the full article click here.
The article is taken from Innovations in Pharmaceutical Technology, July 2017, pages 15-17. © Samedan Ltd